SCHEMBL24725108

SCHEMBL24725108

CS(=O)(=O)c1nccc(OC(F)(F)F)n1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 6/20 0.41
▸ LMNA P02545 6/20 0.41
▸ NPSR1 Q6W5P4 7/20 0.34
▸ HPGD P15428 6/20 0.34
▸ SDHB P21912 6/20 0.34
▸ TP53 P04637 5/20 0.34
▸ KDM4E B2RXH2 5/20 0.34
▸ HTT P42858 5/20 0.34
▸ STAT3 P40763 4/20 0.34
▸ RAB9A P51151 4/20 0.34
▸ ALDH1A1 P00352 4/20 0.34
▸ KMT2A Q03164 4/20 0.34
▸ HSD17B10 Q99714 4/20 0.34
▸ STAT1 P42224 2/20 0.34
▸ TLR9 Q9NR96 2/20 0.34
▸ S1PR4 O95977 2/20 0.34
▸ S1PR1 P21453 2/20 0.34
▸ MAPK1 P28482 2/20 0.34
▸ NPC1 O15118 2/20 0.34
▸ MEN1 O00255 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28858783 0.85 LMNA (0.42) SMN1; SMN2LMNANPSR1TP53HTT
SCHEMBL18382 0.81 NR1H2 (0.41) SMN1; SMN2LMNANPSR1HPGDSDHB
SCHEMBL7270618 0.79 SMN1; SMN2 (0.60) SMN1; SMN2LMNANPSR1HPGDTP53
SCHEMBL8637660 0.78 LMNA (0.37) SMN1; SMN2LMNAPTGS2
SCHEMBL32665306 0.78 LMNA (0.42) SMN1; SMN2LMNANPSR1TP53HTT
SCHEMBL27836920 0.77 KMT2A (0.41) SMN1; SMN2LMNANPSR1TP53KDM4E
SCHEMBL2415488 0.76 KDM4E (0.49) SMN1; SMN2LMNANPSR1HPGDSDHB
SCHEMBL2411422 0.76 SMN1; SMN2 (0.43) SMN1; SMN2LMNANPSR1HPGDTP53
SCHEMBL7696606 0.75 ALDH1A1 (0.43) SMN1; SMN2LMNANPSR1TP53HTT
SCHEMBL7984890 0.74 NUDT1 (0.41) SMN1; SMN2LMNANPSR1TP53HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117677399-A Effective ASGPR binding compounds for the degradation of immunoglobulins and other proteins 阿维拉治疗公司 2024-03-08 — — CN disclosed
WO-2022235699-A2 POTENT ASGPR-BINDING COMPOUNDS FOR THE DEGRADATION OF IMMUNOGLOBULINS AND OTHER PROTEINS AVILAR THERAPEUTICS, INC. (US) 2022-11-10 — — WO disclosed
Send feedback